JP2004256395A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004256395A5 JP2004256395A5 JP2003045510A JP2003045510A JP2004256395A5 JP 2004256395 A5 JP2004256395 A5 JP 2004256395A5 JP 2003045510 A JP2003045510 A JP 2003045510A JP 2003045510 A JP2003045510 A JP 2003045510A JP 2004256395 A5 JP2004256395 A5 JP 2004256395A5
- Authority
- JP
- Japan
- Prior art keywords
- leukocyte migration
- migration ability
- leukocytes
- agent
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000265 leukocyte Anatomy 0.000 claims 6
- 230000005012 migration Effects 0.000 claims 4
- 238000013508 migration Methods 0.000 claims 4
- 102000010445 Lactoferrin Human genes 0.000 claims 2
- 108010063045 Lactoferrin Proteins 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims 2
- 229940078795 lactoferrin Drugs 0.000 claims 2
- 235000021242 lactoferrin Nutrition 0.000 claims 2
- 230000001105 regulatory effect Effects 0.000 claims 2
- 206010033078 Otitis media Diseases 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 206010006451 bronchitis Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 210000002345 respiratory system Anatomy 0.000 claims 1
- 208000037816 tissue injury Diseases 0.000 claims 1
- 241000712461 unidentified influenza virus Species 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003045510A JP2004256395A (ja) | 2003-02-24 | 2003-02-24 | 白血球遊走能調節剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003045510A JP2004256395A (ja) | 2003-02-24 | 2003-02-24 | 白血球遊走能調節剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004256395A JP2004256395A (ja) | 2004-09-16 |
| JP2004256395A5 true JP2004256395A5 (enExample) | 2005-07-14 |
Family
ID=33112290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003045510A Pending JP2004256395A (ja) | 2003-02-24 | 2003-02-24 | 白血球遊走能調節剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2004256395A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105101989B (zh) * | 2013-04-09 | 2019-10-18 | 加贺谷伸治 | 白细胞的细胞外诱捕网形成的抑制剂 |
-
2003
- 2003-02-24 JP JP2003045510A patent/JP2004256395A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bonamonte et al. | Aquarium-borne Mycobacterium marinum skin infection. Report of 15 cases and review of the literature | |
| WO2008149802A1 (ja) | アンドログラホリドを有効成分とする抗疲労剤及び経口組成物 | |
| DE60042598D1 (de) | Medikamente zur behandlung des syndroms der chronishen ermüdung, das mit fibromyalgie und reizdarm assoziert ist. | |
| WO2005023083A3 (en) | Compositions and methods for the treatment of severe acute respiratory syndrome (sars) | |
| WO2005084638A3 (en) | Formulations decreasing infectivity of pulmonary diseases | |
| EP2050444A4 (en) | AGENT FOR REDUCING FATIGUE | |
| EP3927312C0 (en) | MINIMIZING AGGLOMERATION, AERATION AND PRESERVATION OF COATING OF PHARMACEUTICAL COMPOSITIONS WITH IBUPROFEN | |
| JP2006507295A5 (enExample) | ||
| CA2504872A1 (en) | Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections | |
| JP2004256395A5 (enExample) | ||
| Kaur et al. | Dietary antioxidants and infectious diseases | |
| WO2004047829A8 (en) | New synergistic combination comprising roflumilast and formoterol | |
| WO2008075333A3 (en) | Edible compositions for preventing hair loss | |
| JP2018043942A5 (enExample) | ||
| JP2005187427A5 (enExample) | ||
| WO2007057436A3 (en) | Interferon in influenza | |
| SI1567140T1 (sl) | Sinergistična kombinacija, ki obsega roflumilastin (R;R)-formoterol | |
| Alhiti | Nanosilver plus Bacteriophages Cured COVID | |
| JP2006325497A5 (enExample) | ||
| JP2007529478A5 (enExample) | ||
| US20160175443A1 (en) | Treatment options for allergies | |
| TH1901004240A (th) | องค์ประกอบอาหารสัตว์สำหรับการป้องกันหรือการรักษาโรคตับและตับอ่อนตายแบบเฉียบพลัน(AHPND)หรือกลุ่มอาการจุดขาว(WSS)ซึ่งประกอบรวมด้วยสายพันธุ์Bacillussubtilisที่เป็นส่วนประกอบออกฤทธิ์ | |
| WO2008036157A3 (en) | Prophylactic and therapeutic treatment of avian influenza infections in animals | |
| GB202102507D0 (en) | Chemical for the treatment, prevention and control of virus's diseases, bacterial diseases, cardiovascular diseases and lipids | |
| Beveridge | Ethics & effectiveness: prevention, treatment and research for the global pandemic of injury |